A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer Article

Industry Collaboration

cited authors

  • Treat, J. A.; Gonin, R.; Socinski, M. A.; Edelman, M. J.; Catalano, R. B.; Marinucci, D. M.; Ansari, R.; Gillenwater, H. H.; Rowland, K. M.; Comis, R. L.; Obasaju, C. K.; Belani, C. P.; Alpha Oncology Res Network

authors

Publication Date

  • March 1, 2010

webpage

published in

category

keywords

  • NSCLC
  • carboplatin
  • gemcitabine
  • non-platinum doublets
  • paclitaxel
  • phase III

start page

  • 540

end page

  • 547

volume

  • 21

issue

  • 3